Pharmaceutical

Myrobalan Therapeutics secures funding for CNS drug development

Myrobalan Therapeutics has secured $24m in a Series A funding round to develop CNS therapeutics with restorative potential.

Jan 11, 2024 - 18:00
Myrobalan Therapeutics secures funding for CNS drug development
Myrobalan Therapeutics has secured $24m in a Series A funding round to develop CNS therapeutics with restorative potential.
Read the original article

Tags:

Previous Article

GSK’s Nucala for severe eosinophilic asthma gains approval in China

Next Article

Risk adjusted net present value: What is the current valuation of Lumos Pharma’s...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Today’s at-home microbiome testing industry is fraught with snake oil

Opinion: Today’s at-home microbiome testing industry is...

Jan 2, 2024

BioMarin appeases an activist

BioMarin appeases an activist

Dec 21, 2023

STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial

STAT+: Pharmalittle: Employers hire virtual providers a...

Dec 13, 2023